BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Santhera Pharmaceuticals AG 

Im Neuenheimer Feld 518 - 519

Heidelberg    69120  Germany
Phone: 49-0-6221-649-33-0 Fax: 49-0-6221-649-3311


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Santhera Pharmaceuticals AG (SANN.SW) Plunges on European Eye Drug Rejection 1/18/2013 7:37:43 AM    More...
Santhera Pharmaceuticals AG (SANN.SW) and Ipsen Renegotiate Fipamezole Licensing Agreement 1/24/2012 6:02:17 AM    More...
Santhera Pharmaceuticals AG (SANN.SW) and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease; Upfront Payment of 13 Million Euros With Another Milestones of Up To 128 Million Euros 9/3/2010 7:26:17 AM    More...
Santhera Pharmaceuticals AG (SANN.SW) Eyes Approval of Lead Drug, Catena in First Half of 2011 6/16/2010 7:00:01 AM    More...
Santhera Pharmaceuticals AG (SANN.SW)'s MICONOS Trial with Catena/Sovrima in Friedreich's Ataxia Misses Phase 3 Primary Endpoint 5/20/2010 7:33:26 AM    More...
Biovail Pharmaceuticals, Inc., Santhera Pharmaceuticals AG Strike Parkinson's Drug Deal; Santhera Could Pay up to $184 Million 8/24/2009 6:32:40 AM    More...
Santhera Pharmaceuticals AG Cuts Jobs to Slow Cash Burn 7/7/2009 9:09:58 AM    More...
ugichem GmbH to Enter Into Research Collaboration With Santhera Pharmaceuticals AG 3/23/2009 12:17:06 PM    More...
Committee for Medicinal Products for Human Use (CHMP) Confirms Original Opinion on Santhera Pharmaceuticals AG's SNT-MC17/Idebenone for Treatment of Friedreich's Ataxia 11/19/2008 2:33:36 PM    More...
Santhera Pharmaceuticals AG Enrolls Last Patient in Pivotal US Phase III with SNT-MC17/Idebenone in Friedreich's Ataxia 11/11/2008 4:36:27 PM    More...
1234